Pierce Christopher

Insider profile

Pierce Christopher's trades of Prelude Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-04-30 2021-04-29 PlS Planned sale
35,828 -23.2%
363.47
US$1,469,683
35,828 -23.2% 363.47 US$1,469,683
2021-04-15 2021-04-08 PlS Planned sale
45,230 +45.7%
464.13
US$1,818,860
45,230 +45.7% 464.13 US$1,818,860
2020-09-29 2020-09-29 B Purchase
83,871 -6.6%
329.94
US$3,392,689
83,871 -6.6% 329.94 US$3,392,689